Should you have a NCE / NBE that you wish to license, Avicenna can perform a comprehensive valuation of your compound. The valuation report will comprise:

• Product profile covering safety and efficacy aspects, target indication and patient profiles
• Market dynamics including information on competition and products under development
• Intellectual property review
• Risk analysis covering technical, IP and clinical risks
• Valuation based on industry standard model(s) and sensitivity analyses
• An overall assessment of the compound linked to product strategy and pipeline review
• Strategic recommendations covering suggested course of development and alternative paths for early market access.

For more information, please contact our operations team.